Vascular protection from atherosclerosis: Potential of calcium antagonists
- 18 December 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (21) , 16-22
- https://doi.org/10.1016/0002-9149(90)91259-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Atherosclerosis, calcium, and calcium antagonists.Circulation, 1985
- Atherosclerosis: Prevention by Agents Not Affecting Abnormal Levels of Blood LipidsScience, 1981
- Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.Journal of Clinical Investigation, 1980
- Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkeyAtherosclerosis, 1978
- Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. The effect of thiophene compounds.Circulation Research, 1978
- The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits.Circulation Research, 1978
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosisAtherosclerosis, 1975
- Prevention of vascular lesions by chondroitin sulfate a in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing dietAtherosclerosis, 1972
- Effects of agents altering vascular calcium in experimental atherosclerosisAtherosclerosis, 1970